Yutaka Yasunaga

Summary

Affiliation: Osaka National Hospital
Country: Japan

Publications

  1. doi Poorly differentiated neuroendocrine carcinoma of the seminal vesicle
    Yutaka Yasunaga
    Department of Urology, National Hospital Organization Osaka National Hospital, Osaka, Japan
    Int J Urol 19:370-2. 2012
  2. doi Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma
    Atsunari Kawashima
    Department of Urology, Osaka University Graduate School of Medicine, 2 2 Yamadaoka, Suita City, Osaka, 565 0871, Japan
    Med Oncol 29:3298-305. 2012
  3. ncbi [Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma]
    Yutaka Yasunaga
    Department of Urology, National Hospital Organization Osaka National Hospital
    Nihon Hinyokika Gakkai Zasshi 103:540-7. 2012
  4. ncbi [Solitary fibrous tumor of the urinary bladder: a case report]
    Cong Wang
    Department of Urology, National Hospital Organization Osaka National Hospital
    Nihon Hinyokika Gakkai Zasshi 103:640-3. 2012
  5. doi Seminal vesicle metastasis of renal cell carcinoma
    Kyosuke Matsuzaki
    Department of Urology, National Hospital Organization Osaka Medical Center, Osaka, Japan
    Urology 74:1017-8. 2009
  6. doi One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patients
    Atsunari Kawashima
    Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan
    Eur J Cancer 47:1521-6. 2011

Collaborators

  • Norio Nonomura
  • Takafumi Ueda
  • Masao Kuroda
  • Yasuyuki Kojima
  • Atsunari Kawashima
  • Toshitsugu Oka
  • Cong Wang
  • Mikio Nin
  • Akira Tsujimura
  • Yasuyuki Arai
  • Go Tanigawa
  • Motohide Uemura
  • Yasutomo Nakai
  • Kazuo Nishimura
  • Hitoshi Takayama
  • Masatoshi Mukai
  • Kyosuke Matsuzaki
  • Naoki Miyago
  • Yasunori Harada
  • Norio Meguro
  • Kenji Nishimura
  • Akira Nagahara
  • Shigeru Nakamori
  • Hitoshi Inoue
  • Seiji Yamaguchi
  • Dr Susumu Miyoshi
  • Jiro Kajikawa
  • Toshiaki Yoshioka
  • Nobukazu Murosaki
  • Daizo Oka
  • Mototaka Sato
  • Tatsuya Kinoshita
  • Wataru Nakata
  • Tomomi Kishimoto
  • Tsuneo Hara
  • Masashi Nakayama
  • Hideki Sugao
  • Koji Hatano
  • Yasuji Ichikawa
  • Tetsuo Imazu
  • Takuo Koide
  • Shingo Takada
  • Kiyomi Matsumiya
  • Nobuyuki Fujimoto
  • Masato Honda
  • Shigeru Saiki
  • Satoko Fukuda

Detail Information

Publications6

  1. doi Poorly differentiated neuroendocrine carcinoma of the seminal vesicle
    Yutaka Yasunaga
    Department of Urology, National Hospital Organization Osaka National Hospital, Osaka, Japan
    Int J Urol 19:370-2. 2012
    ..The previously biopsied bone tumor was finally diagnosed as a metastasis. A systemic chemotherapy using etoposide and cisplatin failed. The patient died of cancer one-and-a-half years later...
  2. doi Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma
    Atsunari Kawashima
    Department of Urology, Osaka University Graduate School of Medicine, 2 2 Yamadaoka, Suita City, Osaka, 565 0871, Japan
    Med Oncol 29:3298-305. 2012
    ..Continuing therapy for more than one course and maintaining more than 60 % of 1-month relative dose intensity were very important in the prolongation of progression-free survival time regardless of the initial treatment doses...
  3. ncbi [Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma]
    Yutaka Yasunaga
    Department of Urology, National Hospital Organization Osaka National Hospital
    Nihon Hinyokika Gakkai Zasshi 103:540-7. 2012
    ..To validate 2009 TNM classification (7th edition) of renal cell carcinoma (RCC), we reevaluated our RCC database depends on 6th and 7th TNM staging and analyzed a prognostic divergence between subgroups...
  4. ncbi [Solitary fibrous tumor of the urinary bladder: a case report]
    Cong Wang
    Department of Urology, National Hospital Organization Osaka National Hospital
    Nihon Hinyokika Gakkai Zasshi 103:640-3. 2012
    ..MIB-1 index indicated less than 3%, thus the tumor was diagnosed as a solitary fibrous tumor. The patient has no evidence of disease 16 months after the surgery. The current case was the first report in Japan and the twelfth worldwide...
  5. doi Seminal vesicle metastasis of renal cell carcinoma
    Kyosuke Matsuzaki
    Department of Urology, National Hospital Organization Osaka Medical Center, Osaka, Japan
    Urology 74:1017-8. 2009
    ..Vesiclectomy was performed. Pathohistologic examination confirmed a metastatic renal cell carcinoma of the seminal vesicle...
  6. doi One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patients
    Atsunari Kawashima
    Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan
    Eur J Cancer 47:1521-6. 2011
    ..We examined the correlation between relative dose intensity (RDI) and clinical outcome of sorafenib therapy in a multi-institutional study...